Protagonist Therapeutics Announces Positive Topline Results with …
WEBJul 4, 2023 — Protagonist Therapeutics, Inc. ("Protagonist" or "the Company") today announced positive topline results from the Phase 2b FRONTIER 1 clinical trial evaluating the oral interleukin-23...
Protagonist Therapeutics Inc.
WEBMay 13, 2024 — Welcome to Protagonist, a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate.
Protagonist, A Top 1% Biotech, Briefly Breaks Out On Psoriasis …
WEBMay 5, 2023 — Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug. The company is targeting psoriasis with a first-ever ...
Protagonist Announces Two New Phase 3 ICONIC Studies in …
WEBNov 27, 2023 — Protagonist retains all worldwide development and commercialization rights to rusfertide. More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the...
Press Releases - Protagonist Therapeutics Inc.
WEBMay 14, 2024 — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
WEBFeb 2, 2024 — Shares of Protagonist Therapeutics PTGX moved up 14.0% on Thursday after management announced that it is entering into a worldwide license and collaboration agreement with Takeda TAK to develop...
Protagonist Therapeutics, Inc. (PTGX) Stock Price, Quote & News
WEB4 days ago — Get a real-time Protagonist Therapeutics, Inc. (PTGX) stock price quote with breaking news, financials, statistics, charts and more.
Protagonist Therapeutics: Strong Buy Rating on Robust Financials …
WEBMay 7, 2024 — Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of novel constrained peptide-based drug candidates that address...
Protagonist Therapeutics Earns ‘Buy’ Rating: Promising Clinical ...
WEBFeb 9, 2024 — Tim Chiang has given his Buy rating to Protagonist Therapeutics based on a combination of promising factors surrounding the company’s advancements and strategic partnerships.
PTGX Stock Price | Protagonist Therapeutics Inc. Stock Quote (U.S ...
WEB3 days ago — PTGX | Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.